• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.鉴定 P-糖蛋白与两个结合核苷酸的非对称被掩蔽状态:对催化的影响。
J Biol Chem. 2010 Mar 5;285(10):7575-86. doi: 10.1074/jbc.M109.047290. Epub 2010 Jan 8.
2
The nucleotide-binding domains of P-glycoprotein. Functional symmetry in the isolated domain demonstrated by N-ethylmaleimide labelling.P-糖蛋白的核苷酸结合结构域。通过N-乙基马来酰亚胺标记证明分离结构域中的功能对称性。
Eur J Biochem. 2003 Apr;270(7):1483-92. doi: 10.1046/j.1432-1033.2003.03514.x.
3
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.荧光共振能量转移分析表明,P-糖蛋白多药转运体的两个ATP酶活性位点紧密相关。
Biochemistry. 2001 Feb 6;40(5):1413-22. doi: 10.1021/bi002035h.
4
The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.在P-糖蛋白的转运循环中,长春碱结合位点呈现高亲和力和低亲和力两种构象。
Biochemistry. 2001 Dec 25;40(51):15733-42. doi: 10.1021/bi011211z.
5
Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.5'-氟磺酰基苯甲酰 5'-腺苷对多药耐药相关 P-糖蛋白(ABCB1)功能的抑制作用:与药物底物和核苷酸结合位点均相互作用的 ATP 类似物的证据。
Biochemistry. 2011 May 10;50(18):3724-35. doi: 10.1021/bi200073f. Epub 2011 Apr 13.
6
Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.催化循环中核苷酸与P-糖蛋白结合的化学计量学和亲和力。
Biochemistry. 2003 Feb 4;42(4):1170-7. doi: 10.1021/bi026555j.
7
Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis.在核苷酸水解之前,ATP结合会改变P-糖蛋白上的药物结合位点。
Biochemistry. 2000 Oct 3;39(39):11901-6. doi: 10.1021/bi000559b.
8
Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.核苷酸结合域中半胱氨酸残基上P-糖蛋白的定点荧光标记。
Biochemistry. 1996 Sep 10;35(36):11865-73. doi: 10.1021/bi960823u.
9
Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.在人P-糖蛋白催化循环的单次周转过程中,在两个不同步骤需要ATP水解的证据。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2515-20. doi: 10.1073/pnas.97.6.2515.
10
Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.通过胰蛋白酶敏感性监测核苷酸诱导的P-糖蛋白及核苷酸结合位点突变体的构象变化。
Biochemistry. 2000 Apr 18;39(15):4559-68. doi: 10.1021/bi992744z.

引用本文的文献

1
Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies.绘制P-糖蛋白在多药耐药中的作用:近期结构研究的见解
Int J Mol Sci. 2025 Apr 28;26(9):4179. doi: 10.3390/ijms26094179.
2
Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations.通过增强分子动力学模拟揭示的P-糖蛋白配体转运与抑制的机制性见解。
Comput Struct Biotechnol J. 2024 Jun 13;23:2548-2564. doi: 10.1016/j.csbj.2024.06.010. eCollection 2024 Dec.
3
Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.药物诱导的 P-糖蛋白构象动力学是喜树碱类似物转运的基础。
Int J Mol Sci. 2023 Nov 7;24(22):16058. doi: 10.3390/ijms242216058.
4
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.一种靶向钍 227 缀合物在获得性耐药的临床前模型中显示出疗效,并具有与化疗药物和抗血管生成疗法联合应用的潜力。
Mol Cancer Ther. 2023 Sep 5;22(9):1073-1086. doi: 10.1158/1535-7163.MCT-22-0808.
5
Structural basis for substrate and inhibitor recognition of human multidrug transporter MRP4.人多药耐药相关蛋白 4 的底物和抑制剂识别的结构基础。
Commun Biol. 2023 May 22;6(1):549. doi: 10.1038/s42003-023-04935-7.
6
Structure-based alteration of tryptophan residues of the multidrug transporter CmABCB1 to assess substrate binding using fluorescence spectroscopy.基于结构的色氨酸残基修饰评估多药转运蛋白 CmABCB1 的底物结合使用荧光光谱法。
Protein Sci. 2022 Jun;31(6):e4331. doi: 10.1002/pro.4331.
7
Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein.关于多药转运蛋白P-糖蛋白对多特异性底物识别机制的新共识。
Cancer Drug Resist. 2019 Sep 19;2(3):471-489. doi: 10.20517/cdr.2019.22. eCollection 2019.
8
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.基于乳腺癌耐药蛋白(BCRP)及P-糖蛋白/乳腺癌耐药蛋白(P-gp/BCRP)双靶点的多药耐药调节剂研究的最新进展
Cancer Drug Resist. 2019 Sep 19;2(3):710-743. doi: 10.20517/cdr.2019.31. eCollection 2019.
9
Asymmetric drug binding in an ATP-loaded inward-facing state of an ABC transporter.ATP 加载的 ABC 转运蛋白的内向构象中药物的不对称结合。
Nat Chem Biol. 2022 Feb;18(2):226-235. doi: 10.1038/s41589-021-00936-x. Epub 2021 Dec 20.
10
The Structure and Mechanism of Drug Transporters.药物转运体的结构与机制。
Methods Mol Biol. 2021;2342:193-234. doi: 10.1007/978-1-0716-1554-6_8.

本文引用的文献

1
Interaction of LDS-751 with the drug-binding site of P-glycoprotein: a Trp fluorescence steady-state and lifetime study.LDS-751与P-糖蛋白药物结合位点的相互作用:色氨酸荧光稳态和寿命研究
Arch Biochem Biophys. 2009 Dec;492(1-2):17-28. doi: 10.1016/j.abb.2009.10.002. Epub 2009 Oct 8.
2
ABC efflux pump-based resistance to chemotherapy drugs.基于ABC外排泵的化疗药物耐药性。
Chem Rev. 2009 Jul;109(7):2989-3011. doi: 10.1021/cr9000226.
3
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.P-糖蛋白的结构揭示了多特异性药物结合的分子基础。
Science. 2009 Mar 27;323(5922):1718-22. doi: 10.1126/science.1168750.
4
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.P-糖蛋白的结构、功能与调控及其在药物处置中的临床意义
Xenobiotica. 2008 Jul;38(7-8):802-32. doi: 10.1080/00498250701867889.
5
Structure, function, and evolution of bacterial ATP-binding cassette systems.细菌ATP结合盒转运系统的结构、功能及进化
Microbiol Mol Biol Rev. 2008 Jun;72(2):317-64, table of contents. doi: 10.1128/MMBR.00031-07.
6
Crystal structure of a catalytic intermediate of the maltose transporter.麦芽糖转运蛋白催化中间体的晶体结构。
Nature. 2007 Nov 22;450(7169):515-21. doi: 10.1038/nature06264.
7
Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP.P-糖蛋白催化ATP水解的循环过程:与ATP-γ-S(一种ATP的不可水解类似物)形成E.S反应中间体的证据。
Biochemistry. 2007 Dec 4;46(48):13787-99. doi: 10.1021/bi701385t. Epub 2007 Nov 8.
8
Structure and function of ABC transporters.ABC转运蛋白的结构与功能。
Physiology (Bethesda). 2007 Apr;22:122-30. doi: 10.1152/physiol.00046.2006.
9
Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP.金黄色葡萄球菌多药ABC转运蛋白Sav1866与AMP-PNP复合物的结构
FEBS Lett. 2007 Mar 6;581(5):935-8. doi: 10.1016/j.febslet.2007.01.073. Epub 2007 Feb 7.
10
About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work.关于一种开关:P-糖蛋白(ABCB1)如何利用ATP结合与水解的能量来执行机械功。
Mol Cancer Ther. 2007 Jan;6(1):13-23. doi: 10.1158/1535-7163.MCT-06-0155.

鉴定 P-糖蛋白与两个结合核苷酸的非对称被掩蔽状态:对催化的影响。

Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.

机构信息

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.

出版信息

J Biol Chem. 2010 Mar 5;285(10):7575-86. doi: 10.1074/jbc.M109.047290. Epub 2010 Jan 8.

DOI:10.1074/jbc.M109.047290
PMID:20061384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2844205/
Abstract

P-glycoprotein (ABCB1), a member of the ABC superfamily, functions as an ATP-driven multidrug efflux pump. The catalytic cycle of ABC proteins is believed to involve formation of a sandwich dimer in which two ATP molecules are bound at the interface of the nucleotide binding domains (NBDs). However, such dimers have only been observed in isolated NBD subunits and catalytically arrested mutants, and it is still not understood how ATP hydrolysis is coordinated between the two NBDs. We report for the first time the characterization of an asymmetric state of catalytically active native P-glycoprotein with two bound molecules of adenosine 5'-(gamma-thio)triphosphate (ATPgammaS), one of low affinity (K(d) 0.74 mm), and one "occluded" nucleotide of 120-fold higher affinity (K(d) 6 microm). ATPgammaS also interacts with P-glycoprotein with high affinity as assessed by inhibition of ATP hydrolysis and protection from covalent labeling of a Walker A Cys residue, whereas other non-hydrolyzable ATP analogues do not. Binding of ATPgammaS (but not ATP) causes Trp residue heterogeneity, as indicated by collisional quenching, suggesting that it may induce conformational asymmetry. Asymmetric ATPgammaS-bound P-glycoprotein does not display reduced binding affinity for drugs, implying that transport is not driven by ATP binding and likely takes place at a later stage of the catalytic cycle. We propose that this asymmetric state with two bound nucleotides represents the next intermediate on the path toward ATP hydrolysis after nucleotide binding, and an alternating sites mode of action is achieved by simultaneous switching of the two active sites between high and low affinity states.

摘要

P-糖蛋白(ABCB1)是 ABC 超家族的成员,作为一种 ATP 驱动的多药外排泵发挥作用。人们认为 ABC 蛋白的催化循环涉及夹心二聚体的形成,其中两个 ATP 分子结合在核苷酸结合域(NBD)的界面上。然而,这种二聚体仅在分离的 NBD 亚基和催化捕获突变体中观察到,并且仍然不清楚如何协调两个 NBD 之间的 ATP 水解。我们首次报道了具有两个结合的腺苷 5' - (γ-硫)三磷酸(ATPγS)分子的催化活性天然 P-糖蛋白的不对称状态的特征,其中一个亲和力较低(Kd 0.74mm),而另一个“封闭”核苷酸的亲和力高 120 倍(Kd 6μm)。正如通过抑制 ATP 水解和保护 Walker A Cys 残基的共价标记来评估的那样,ATPγS 也与 P-糖蛋白高亲和力相互作用,而其他不可水解的 ATP 类似物则没有。ATPγS 的结合(而不是 ATP)引起色氨酸残基的异质性,如碰撞猝灭所表明的,表明它可能诱导构象不对称。不对称的 ATPγS 结合的 P-糖蛋白对药物的结合亲和力没有降低,这意味着运输不是由 ATP 结合驱动的,并且可能发生在催化循环的后期。我们提出,这种具有两个结合核苷酸的不对称状态代表核苷酸结合后向 ATP 水解的下一个中间状态,并且通过两个活性位点在高亲和力状态和低亲和力状态之间的同时切换来实现交替结合位点的作用模式。